US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
CA2328496C
(fr)
|
1998-05-15 |
2016-01-05 |
Genentech, Inc. |
Polypeptides homologues de il-17 et utilisations therapeutiques de ceux-ci
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
WO2000050565A2
(fr)
*
|
1999-02-25 |
2000-08-31 |
Thomas Jefferson University |
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
WO2000050458A1
(fr)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Clonage du recepteur 7tm (axor 17) du type p2y
|
CA2365238A1
(fr)
*
|
1999-03-23 |
2000-09-28 |
Human Genome Sciences, Inc. |
48 proteines humaines secretees
|
EP1174509A4
(fr)
*
|
1999-03-29 |
2003-10-22 |
Kansai Tech Licensing Org Co |
Nouvelle cytidine desaminase
|
EP1623991A3
(fr)
*
|
1999-09-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
|
AU1238201A
(en)
*
|
1999-10-27 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Novel molecules and the card-related protein family and uses thereof
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
EP1878795A3
(fr)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions et procédés pour le traitement de maladies liées au système immunitaire
|
JP2004522404A
(ja)
*
|
1999-12-01 |
2004-07-29 |
ジェネンテック・インコーポレーテッド |
分泌及び膜貫通ポリペプチドとそれをコードしている核酸
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
ATE392474T1
(de)
|
2000-01-26 |
2008-05-15 |
Agensys Inc |
84p2a9: prostata- und testis-spezifisches protein das hohe expression in prostatakrebs aufweist
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
EP1268791A2
(fr)
*
|
2000-03-23 |
2003-01-02 |
Immusol Incorporated |
Regulateurs de brca-1 et procedes d'utilisation
|
EP1272640A2
(fr)
|
2000-03-24 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, et 13887 nouvelles molecules de proteine kinase et leurs utilisations
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
AU2001257195B2
(en)
|
2000-04-25 |
2006-10-05 |
Lexicon Pharmaceuticals, Inc. |
Novel human kinase proteins and polynucleotides encoding the same
|
WO2001081586A2
(fr)
*
|
2000-04-26 |
2001-11-01 |
Millennium Pharmaceuticals, Inc. |
21657, deshydrogenase humaine a chaine courte et ses utilisations
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
WO2001085921A2
(fr)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gmbh |
Nouvelle serine-threonine kinase-4
|
EP1307545A2
(fr)
*
|
2000-05-26 |
2003-05-07 |
Bayer Aktiengesellschaft |
Regulation de la serine/threonine kinase humaine analogue a p78
|
EP1158001B1
(fr)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
WO2001093805A2
(fr)
*
|
2000-06-02 |
2001-12-13 |
The Brigham & Women's Hospital, Inc. |
Fusion de genes jazf1 et jjaz1 dans des tumeurs stromatolithiques endometriales
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1292677A2
(fr)
*
|
2000-06-05 |
2003-03-19 |
Bayer Aktiengesellschaft |
Regulation du recepteur couple a la proteine humaine g de type hm74
|
WO2001096390A2
(fr)
*
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions et procedes pour la therapie et le diagnostic du cancer du colon
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
EP1290193A2
(fr)
*
|
2000-06-16 |
2003-03-12 |
Incyte Genomics, Inc. |
Proteine phosphatase
|
CA2648051A1
(fr)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
|
WO2002000861A2
(fr)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
46619, une nouvelle synthase beta-cetoacyle et utilisations de cette derniere
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
US20030149237A1
(en)
*
|
2000-06-27 |
2003-08-07 |
Corine Vernet |
Novel polynucleotides and polypeptides encoded thereby
|
WO2002000939A2
(fr)
|
2000-06-28 |
2002-01-03 |
Diadexus, Inc. |
Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
|
US6900303B2
(en)
|
2000-06-30 |
2005-05-31 |
Millennium Pharmaceuticals, Inc. |
57658, a novel human uridine kinase and uses thereof
|
AU2001273239A1
(en)
*
|
2000-07-07 |
2002-01-21 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
WO2002004510A2
(fr)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Proteines liant le nucleotide guanine
|
EP1305428A2
(fr)
*
|
2000-07-14 |
2003-05-02 |
Millennium Pharmaceuticals, Inc. |
62088, un nouveau membre humain de la famille nucleoside phosphatase, et utilisations de ce dernier
|
WO2002006318A2
(fr)
*
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Procedes et compositions permettant de stabiliser des microtubules et des filaments intermediaires dans des cellules de muscle strie
|
JP2004504026A
(ja)
*
|
2000-07-18 |
2004-02-12 |
バイエル アクチェンゲゼルシャフト |
ヒトdesc1様セリンプロテアーゼの調節
|
AU2001273150A1
(en)
*
|
2000-07-20 |
2002-02-05 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20060252034A1
(en)
*
|
2000-07-25 |
2006-11-09 |
Klaus Duecker |
Novel protein containing ring finger domaine r1p4
|
WO2002008282A2
(fr)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Proteine bstp-ras/rerg et reactifs apparentes, procedes d'utilisation de ces derniers
|
AU2001277200A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-cad protein and related reagents and methods of use thereof
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
EP1657254A3
(fr)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
|
US7402660B2
(en)
|
2000-08-02 |
2008-07-22 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
WO2003024276A1
(fr)
*
|
2000-08-02 |
2003-03-27 |
Millennium Pharmaceuticals,Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
US6924364B2
(en)
|
2000-08-04 |
2005-08-02 |
Zymogenetics, Inc. |
Human secreted protein, Zzp1
|
AU2001281252A1
(en)
|
2000-08-10 |
2002-02-18 |
Board Of Regents, The University Of Texas System |
The tumor suppressor car-1
|
AU9174501A
(en)
*
|
2000-08-11 |
2002-02-25 |
Merck Patent Gmbh |
Novel mitogen activated kinase
|
EP1326985A1
(fr)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification d'un gene d'acetyltransferase n-terminale humaine
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
US6962799B2
(en)
*
|
2000-08-21 |
2005-11-08 |
Incyte Corporation |
Microtubule-associated proteins and tubulins
|
WO2002016579A2
(fr)
*
|
2000-08-24 |
2002-02-28 |
Eli Lilly And Company |
Acides nucleiques, vecteurs, cellules hotes, polypeptides et utilisations de ces derniers
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
EP1313850B1
(fr)
|
2000-08-28 |
2008-08-06 |
Agensys, Inc. |
Acide nucleique et proteine correspondante denommes 85p1b3 utilises dans le traitement et la detection de cancers
|
EP1313761A4
(fr)
*
|
2000-08-28 |
2005-01-26 |
Human Genome Sciences Inc |
18 proteines humaines secretees
|
AU2001286815A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
48921, a novel human gtp releasing factor and uses therefor
|
WO2002018552A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation d'enzyme humaine de type aminotransferase
|
WO2002018567A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation d'enzyme humaine de type aminotransferase
|
WO2002018573A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
Nouveau transporteur humain de sulfate: la proteine 54370, et utilisations associees
|
US7166428B2
(en)
|
2000-08-31 |
2007-01-23 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
DE60138715D1
(de)
|
2000-09-05 |
2009-06-25 |
Amgen Inc |
Tnf-rezeptor-ähnliche moleküle und deren anwendungen
|
EP1364015A2
(fr)
*
|
2000-09-05 |
2003-11-26 |
Incyte Genomics, Inc. |
Molecules pour diagnostic et traitement
|
AU2001288999A1
(en)
*
|
2000-09-08 |
2002-03-22 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
US20040048245A1
(en)
*
|
2000-10-05 |
2004-03-11 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
WO2002031126A2
(fr)
*
|
2000-10-11 |
2002-04-18 |
Bayer Aktiengesellschaft |
Regulation d'une peptidyl-prolyl cis-trans isomerase de type cyclophiline humaine
|
EP1402010A2
(fr)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier
|
AU2002211715A1
(en)
*
|
2000-10-12 |
2002-04-22 |
The Texas A And M University System |
Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use
|
WO2002030268A2
(fr)
*
|
2000-10-13 |
2002-04-18 |
Eos Biotechnology, Inc. |
Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
WO2002062945A2
(fr)
|
2000-10-25 |
2002-08-15 |
Diadexus, Inc. |
Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
AU2002219988A1
(en)
|
2000-11-20 |
2002-05-27 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
AU2001297765A1
(en)
*
|
2000-12-05 |
2002-10-21 |
Incyte Genomics, Inc. |
Ligases
|
AU2002226033A1
(en)
|
2000-12-07 |
2002-06-18 |
Zymogenetics Inc. |
Adipocyte complement related protein zacrp3x2
|
JP2004535765A
(ja)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
AU2002211305A1
(en)
*
|
2000-12-14 |
2002-06-24 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6858407B2
(en)
|
2000-12-22 |
2005-02-22 |
Bristol-Myers Squibb Company |
Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2002053591A1
(fr)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
|
AU2002236717A1
(en)
*
|
2001-01-08 |
2002-07-16 |
Lexicon Genetics Incorporated |
Human protease and polynucleotides encoding the same
|
CA2436661A1
(fr)
*
|
2001-01-30 |
2002-08-08 |
Regeneron Pharmaceuticals, Inc. |
Nouvelles molecules d'acide nucleique et polypeptidiques
|
CA2438571A1
(fr)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
|
EP1637601A3
(fr)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
WO2002074906A2
(fr)
*
|
2001-03-16 |
2002-09-26 |
Eli Lilly And Company |
Proteines de mammiferes lp et reactifs associes
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
WO2002083860A2
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acide nucleique et proteine correspondante appelee 151p3d4 utiles dans le traitement et la detection du cancer
|
CA2442993C
(fr)
|
2001-04-10 |
2011-10-11 |
Agensys, Inc. |
Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer
|
CA2443123A1
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
|
US20040175763A1
(en)
*
|
2001-04-24 |
2004-09-09 |
Hiroshi Saito |
Crohn's disease antibody-binding peptide and method of examining crohn's disease
|
EP1383883A2
(fr)
*
|
2001-04-24 |
2004-01-28 |
Isis Innovation Limited |
Snps asthme-associes autour du marqueur d2s308 de microsatellite et de l'identification de prolyl-oligopeptidase-dpp10 humain
|
WO2002090546A1
(fr)
*
|
2001-05-07 |
2002-11-14 |
Shionogi & Co., Ltd. |
Polypeptide servant de marqueur angiogenique et son adn
|
AU2002314048A1
(en)
*
|
2001-05-09 |
2002-11-18 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003000901A2
(fr)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Acides nucleiques codant des proteines kinases
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
GB2399085A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ12
|
WO2003031568A2
(fr)
*
|
2001-08-17 |
2003-04-17 |
Incyte Genomics, Inc. |
Molecules de signalisation intracellulaire
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
EP1463806B1
(fr)
|
2001-09-28 |
2011-01-05 |
Brigham Young University |
Nouveaux variants de la cyclooxygenase et methodes d'utilisation
|
JPWO2003038087A1
(ja)
|
2001-10-04 |
2005-02-24 |
関西ティー・エル・オー株式会社 |
DR5遺伝子のプロモーターおよびSiah−1遺伝子のプロモーター
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003031607A1
(fr)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation de deshydrogenase/reductase des chaines courtes humaine
|
ATE364690T1
(de)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
Posh nukleinsäure, polypeptide und darauf bezogene verfahren
|
AU2002365162A1
(en)
|
2001-11-14 |
2003-07-09 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
CA2468145A1
(fr)
*
|
2001-11-21 |
2003-05-30 |
Japan Science And Technology Agency |
Facteurs de transcription de gene de la choree de huntington
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
WO2003051911A2
(fr)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Polypeptides et polynucleotides gmg-5 et utilisations de ceux-ci
|
JP2003245084A
(ja)
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
WO2003057870A1
(fr)
*
|
2002-01-07 |
2003-07-17 |
Bayer Healthcare Ag |
Proteine humaine analogue a la phosphatase de l'acide phosphatidique de type 2
|
WO2003059948A1
(fr)
*
|
2002-01-15 |
2003-07-24 |
Medigene Ag |
Gene-2 associe a la myocardiopathie dilatee (dcmag-2) : inducteur cytoplasmique du remodelage sarcomerique de cardiomyocytes
|
AU2003235631A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Bayer Aktiengesellschaft |
Human subtilisin/kexin-like convertase
|
JPWO2003062429A1
(ja)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
新規セリンプロテアーゼ
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
EP1338609A1
(fr)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Un outre récepteur KDR et son utilisation
|
US20060100417A1
(en)
*
|
2002-03-05 |
2006-05-11 |
Xianghe Yan |
Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
|
GB2388113A
(en)
*
|
2002-03-06 |
2003-11-05 |
Oxford Glycosciences |
B-cell malignancy-associated protein
|
WO2003078662A1
(fr)
|
2002-03-13 |
2003-09-25 |
Genomic Health |
Profilage d'expression genique dans des tissus tumoraux ponctionnes
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
JP3949111B2
(ja)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
新規gタンパク質共役型受容体およびその遺伝子
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのdnaおよびその用途
|
EP1507553A2
(fr)
|
2002-05-29 |
2005-02-23 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Proteines specifiques du pancreas
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
CA2488404C
(fr)
|
2002-06-06 |
2012-11-27 |
Oncotherapy Science, Inc. |
Genes et polypeptides en rapport avec les cancers du colon chez l'homme
|
US8518694B2
(en)
|
2002-06-13 |
2013-08-27 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
|
EP1541586A4
(fr)
*
|
2002-07-22 |
2006-08-09 |
Astellas Pharma Inc |
Nouveau gene associe a l'arthrite rhumatoide
|
JP4186004B2
(ja)
|
2002-08-14 |
2008-11-26 |
独立行政法人産業技術総合研究所 |
新規n−アセチルガラクトサミン転移酵素およびそれをコードする核酸
|
US20040081653A1
(en)
*
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
WO2004020662A2
(fr)
*
|
2002-08-27 |
2004-03-11 |
Epigenomics Ag |
Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
DE60325628D1
(de)
|
2002-09-30 |
2009-02-12 |
Oncotherapy Science Inc |
Gene und polypeptide in verbindung mit menschlichen pankreaskarzinomen
|
AU2003294696A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
JP4606879B2
(ja)
|
2002-11-15 |
2011-01-05 |
ジェノミック ヘルス, インコーポレイテッド |
Egfr陽性癌の遺伝子発現プロファイリング
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
EP1445614A1
(fr)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu
|
US7074891B2
(en)
*
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
JP4568716B2
(ja)
|
2003-02-20 |
2010-10-27 |
ジェノミック ヘルス, インコーポレイテッド |
遺伝子発現を測定するためのイントロンrnaの使用
|
WO2004078784A1
(fr)
*
|
2003-03-04 |
2004-09-16 |
Astellas Pharma Inc. |
Nouveau gene associe a des conditions fibreuses
|
RS54160B1
(sr)
|
2003-03-19 |
2015-12-31 |
Biogen Idec Ma Inc. |
Protein koji se vezuje za nogo receptor
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
DK1641810T4
(en)
|
2003-06-24 |
2017-07-03 |
Genomic Health Inc |
Predicting the likelihood of cancer recurrence
|
ES2651849T3
(es)
|
2003-07-10 |
2018-01-30 |
Genomic Health, Inc. |
Algoritmo del perfil de expresión y test para el pronóstico del cáncer
|
EP2311468B1
(fr)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gène surexprimé dans le cancer
|
WO2005018554A2
(fr)
*
|
2003-08-12 |
2005-03-03 |
Washington University In St. Louis |
Proteine de surface cellulaire isolee inductible par la chaleur et therapie d'immunociblage de tumeurs basee sur l'hyperthermie
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
DE602004028262D1
(de)
*
|
2003-10-02 |
2010-09-02 |
Glaxosmithkline Biolog Sa |
B. pertussis antigene und ihre verwendung bei der vakzinierung
|
WO2005033144A2
(fr)
|
2003-10-03 |
2005-04-14 |
Brigham And Women's Hospital |
Ligands de tim-3 et methodes associees
|
WO2005040791A2
(fr)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr)
|
WO2005051994A2
(fr)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Facteur de necrose tumorale ztnf11
|
EP1696945B1
(fr)
|
2003-12-05 |
2012-01-18 |
Northwestern University |
Amphiphiles peptidiques a assemblage automatique et procedes associes d'administration de facteur de croissance
|
ATE498022T1
(de)
|
2003-12-23 |
2011-02-15 |
Genomic Health Inc |
Universelle vervielfältigung von fragmentierter rns
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
ES2437590T3
(es)
|
2004-03-02 |
2014-01-13 |
The Johns-Hopkins University |
Mutaciones del gen de PIK3CA en cánceres humanos
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
WO2005090569A1
(fr)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
|
CA2561577A1
(fr)
|
2004-03-30 |
2005-10-13 |
Nsgene A/S |
Utilisation therapeutique d'un facteur de croissance, nsg33
|
ES2550614T3
(es)
|
2004-04-09 |
2015-11-11 |
Genomic Health, Inc. |
Marcadores de expresión génica para predecir la respuesta a la quimioterapia
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
WO2005118832A2
(fr)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl)
|
KR101239542B1
(ko)
|
2004-06-24 |
2013-03-07 |
바이오겐 아이덱 엠에이 인코포레이티드 |
탈수초화를 수반하는 병의 치료
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
US7985831B2
(en)
*
|
2004-08-05 |
2011-07-26 |
Toagosei Co., Ltd. |
Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease
|
EP1836629B1
(fr)
|
2004-11-05 |
2020-03-04 |
Genomic Health, Inc. |
Prediction de reaction a la chimiotherapie au moyen de marqueurs d'expression genique
|
DK1815014T3
(da)
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molekylære indikatorer for brystcancerprognose og forudsigelse af behandlingsrespons
|
EP2332985A3
(fr)
|
2004-11-12 |
2012-01-25 |
Xencor, Inc. |
Variants de Fc avec une liaison altérée à fcrn
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
MX2007010771A
(es)
|
2005-03-04 |
2008-03-10 |
Univ Northwestern |
Anfifilos peptidicos para union a heparina angiogenicos.
|
WO2006120019A2
(fr)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
|
RS53058B
(en)
|
2005-07-08 |
2014-04-30 |
Biogen Idec Ma Inc. |
SP35 ANTIBODIES AND THEIR APPLICATIONS
|
EP1907589A4
(fr)
*
|
2005-07-26 |
2010-11-24 |
Siemens Healthcare Diagnostics |
Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
|
WO2007037601A1
(fr)
*
|
2005-09-28 |
2007-04-05 |
Knu-Industry Cooperation Foundation |
Polypeptide inhibant la transmigration de leucocytes ou la croissance et/ou la métastase de cellules cancéreuses, et une protéine de fusion de celui-ci
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
PL1969003T3
(pl)
|
2005-12-14 |
2011-05-31 |
Herantis Pharma Plc |
Zastosowanie białka czynnika neurotroficznego
|
US20120141376A1
(en)
*
|
2006-07-03 |
2012-06-07 |
Richard Einstein |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
EP2066810A2
(fr)
*
|
2006-09-08 |
2009-06-10 |
Corixa Corporation |
Procédés, compositions, et kits de détection et de surveillance d'un cancer du colon
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
CA2694805C
(fr)
*
|
2007-07-27 |
2014-09-09 |
Immatics Biotechnologies Gmbh |
Nouveaux epitopes immunogenes destines a l'immunotherapie
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
WO2009034661A1
(fr)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Procédé de diagnostic et induction d'une résistance à un virus
|
ES2401233T3
(es)
|
2007-10-17 |
2013-04-18 |
Universidad de Córdoba |
Isoformas del receptor tipo 5 de somatostatina humana producidas por tratamiento alternativo y pares de oligonucleótidos para la detección de las mismas por PCR
|
SI2235059T1
(sl)
|
2007-12-26 |
2015-06-30 |
Xencor, Inc. |
Fc variante s spremenjeno vezjo na fcrn
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
EP2307451B1
(fr)
*
|
2008-03-21 |
2016-05-25 |
Universiteit Hasselt |
Biomarqueurs de la polyarthrite rhumatoïde
|
DK2982695T3
(da)
|
2008-07-09 |
2019-05-13 |
Biogen Ma Inc |
Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
|
EP2195013B1
(fr)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Utilisation thérapeutique d'un facteur de croissance, metrnl
|
PT2172211E
(pt)
|
2008-10-01 |
2015-03-09 |
Immatics Biotechnologies Gmbh |
Composição de peptídeos associados a tumores e vacina anti -cancro relacionada para o tratamento de glioblastoma (gbm) e outros tipos de câncer
|
US8637249B2
(en)
|
2008-11-14 |
2014-01-28 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of Campylobacter nucleic acid
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
US20110286924A1
(en)
*
|
2008-12-09 |
2011-11-24 |
Alethia Biotherapeutics Inc |
Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
|
WO2010120830A1
(fr)
|
2009-04-13 |
2010-10-21 |
Northwestern University |
Nouvelles structures peptidiques pour la régénération des cartilages et procédés pour les utiliser
|
WO2011028952A1
(fr)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions et procédés pour une co-liaison bivalente et monovalente simultanée d'antigènes
|
CA2787940C
(fr)
*
|
2010-01-27 |
2020-01-07 |
Massachusetts Institute Of Technology |
Agents polypeptidiques techniques pour la neutralisation de la grippe a large spectre ciblee
|
IL311145A
(en)
|
2010-09-29 |
2024-04-01 |
Seagen Inc |
Antibody drug conjugates (ADC) binding to 191P4D12 proteins
|
AU2011307488B2
(en)
|
2010-10-01 |
2015-08-20 |
Hoba Therapeutics Aps |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
EP2651430B1
(fr)
*
|
2010-12-14 |
2018-06-06 |
Hananja Ehf |
Activité biologique de la protéine placentaire 13
|
EP2753347B1
(fr)
|
2011-09-05 |
2016-08-03 |
NsGene A/S |
Traitement de l'allodynie, de l'hyperalgie, de la douleur spontanée et de la douleur illusionnelle
|
AR088699A1
(es)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
Diacilglicerol lipasa y usos de la misma
|
CA3004695C
(fr)
|
2012-04-30 |
2020-08-04 |
Biocon Limited |
Proteines de fusion ciblees/immunomodulatrices et leurs procedes de fabrication
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
NZ702178A
(en)
|
2012-05-14 |
2017-01-27 |
Biogen Ma Inc |
Lingo-2 antagonists for treatment of conditions involving motor neurons
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
JP6499079B2
(ja)
|
2012-11-13 |
2019-04-10 |
バイオエヌテック アーゲーBioNTech AG |
クローディンを発現するガン疾患を処置するための剤
|
WO2014127785A1
(fr)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
WO2014146672A1
(fr)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
|
CN112870368A
(zh)
|
2013-03-27 |
2021-06-01 |
西达-赛奈医疗中心 |
通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症
|
CA2917348A1
(fr)
|
2013-07-11 |
2015-01-15 |
Moderna Therapeutics, Inc. |
Compositions comprenant des polynucleotides synthetiques codant pour des proteines liees a crispr et des arnsg synthetiques et methodes d'utilisation
|
EP3022295A4
(fr)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature de la voie de signalisation de tl1a (tnfsf15)
|
AU2014324884B2
(en)
|
2013-09-25 |
2020-03-26 |
Cytomx Therapeutics, Inc |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
JP6558699B2
(ja)
|
2013-10-01 |
2019-08-14 |
国立大学法人三重大学 |
抗原提示を促進するエピトープ間配列を含むt細胞誘導ワクチン
|
DK3628328T3
(da)
|
2014-01-31 |
2022-12-05 |
Cytomx Therapeutics Inc |
Matriptase- og u-plasminogen-aktivatorsubstrater og andre spaltelige dele og fremgangsmåder til anvendelse deraf
|
AU2016205197B2
(en)
|
2015-01-08 |
2021-10-21 |
Biogen Ma Inc. |
LINGO-1 antagonists and uses for treatment of demyelinating disorders
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
EP3307070A4
(fr)
*
|
2015-06-12 |
2019-01-02 |
Emory University |
Compositions de croissance et de survie pour des cellules capables de produire des anticorps et procédés associés
|
EP3344776B1
(fr)
*
|
2015-09-04 |
2021-06-16 |
Synthetic Genomics, Inc. |
Micro-organisme recombinant algal de productivité accrue
|
EP3430172A4
(fr)
|
2016-03-17 |
2019-08-21 |
Cedars-Sinai Medical Center |
Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
|
US20200330606A1
(en)
*
|
2016-03-29 |
2020-10-22 |
Valkyrie Therapeutics Inc. |
Modulation of structural maintenance of chromosome-1 expression
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
EP3508499A1
(fr)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations
|
CN114269926A
(zh)
*
|
2019-04-26 |
2022-04-01 |
美商圣加莫治疗股份有限公司 |
Aav工程化
|
JP2022538688A
(ja)
|
2019-07-05 |
2022-09-05 |
イオックス セラピューティクス アーゲー |
IGSF11(VSIG3)のIgC2に結合する抗体及びその使用
|
WO2021083958A1
(fr)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Nouveaux peptides induisant la satiété
|
WO2021228999A1
(fr)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Épitopes néo-antigéniques associés à des mutations sf3b1
|
EP4175668A1
(fr)
|
2020-07-06 |
2023-05-10 |
iOmx Therapeutics AG |
Anticorps de liaison à l'igv d'igsf11 (vsig3) et leurs utilisations
|
CA3205170A1
(fr)
*
|
2021-01-21 |
2022-07-28 |
Johannes Eduard Maria Antonius Debets |
Lymphocytes t destines a etre utilises en therapie
|
EP4294403A1
(fr)
*
|
2021-02-18 |
2023-12-27 |
Beren Therapeutics P.B.C. |
Méthodes de traitement de l'hypercholestérolémie familiale hétérozygote et homozygote avec des cyclodextrines
|
US20240158457A1
(en)
*
|
2022-05-20 |
2024-05-16 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|